<- Go Home

DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

Market Cap

$33.1B

Volume

4.0M

Cash and Equivalents

$621.2M

EBITDA

$840.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$2.4B

Profit Margin

61.68%

52 Week High

$142.00

52 Week Low

$62.34

Dividend

N/A

Price / Book Value

16.75

Price / Earnings

50.88

Price / Tangible Book Value

17.92

Enterprise Value

$33.2B

Enterprise Value / EBITDA

38.04

Operating Income

$628.0M

Return on Equity

32.06%

Return on Assets

6.06

Cash and Short Term Investments

$2.5B

Debt

$2.6B

Equity

$2.0B

Revenue

$4.0B

Unlevered FCF

$365.1M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches